Clinical Trials Logo

Clinical Trial Summary

This is a clinical study to comparatively evaluate the impact of Drawtex wound dressing against wound bioburden in moderately to highly exuding venous leg ulcers.


Clinical Trial Description

Each subject is expected to participate in this study for a period of four weeks or until reepithelialization, whichever occurs first. Subjects may participate for an additional period of four weeks or until reepithelialization, whichever occurs first: this it to be decided by the investigator and will be determined by the accessibility of the patient (physical location) and the suitability of the wound to further treatment. The maximum time period for the study is 8 weeks. The minimum time frame is at least 4 week, or until reepithelialization occurs. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01319123
Study type Interventional
Source Southwest Regional Wound Care Center
Contact
Status Completed
Phase N/A
Start date October 2010
Completion date August 2011